• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus.金黄色葡萄球菌基因相关菌株中氟喹诺酮耐药机制
Antimicrob Agents Chemother. 1997 Dec;41(12):2733-7. doi: 10.1128/AAC.41.12.2733.
2
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.金黄色葡萄球菌中诱导型NorA介导的多重耐药性。
Antimicrob Agents Chemother. 1995 Dec;39(12):2650-5. doi: 10.1128/AAC.39.12.2650.
3
Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.金黄色葡萄球菌对溴化乙锭的外排介导反应。
J Antimicrob Chemother. 2008 Sep;62(3):504-13. doi: 10.1093/jac/dkn217. Epub 2008 May 28.
4
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.由norA介导的喹诺酮耐药性:生理学特征及其与flqB的关系,flqB是金黄色葡萄球菌染色体上的一个喹诺酮耐药位点。
Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55. doi: 10.1128/AAC.38.6.1345.
5
Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.利用质粒整合将norA启动子区域突变引入对氟喹诺酮敏感的金黄色葡萄球菌菌株的染色体中。
Antimicrob Agents Chemother. 1999 Sep;43(9):2222-4. doi: 10.1128/AAC.43.9.2222.
6
Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.来自日本和中国的喹诺酮耐药及耐甲氧西林金黄色葡萄球菌分离株中4-喹诺酮耐药机制
J Med Microbiol. 1995 Mar;42(3):214-9. doi: 10.1099/00222615-42-3-214.
7
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.拓扑异构酶IV中的喹诺酮耐药性突变:与flqA位点的关系以及金黄色葡萄球菌中拓扑异构酶IV是氟喹诺酮类药物的主要靶点而DNA回旋酶是次要靶点的遗传学证据。
Antimicrob Agents Chemother. 1996 Aug;40(8):1881-8. doi: 10.1128/AAC.40.8.1881.
8
Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus.耐氟喹诺酮且对甲氧西林敏感及耐药的金黄色葡萄球菌临床分离株中的拓扑异构酶突变
Antimicrob Agents Chemother. 1998 Jan;42(1):197-8. doi: 10.1128/AAC.42.1.197.
9
Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by Phyllanthin.叶下珠 Schumach. & Thonn 的抗菌活性和叶下珠素对金黄色葡萄球菌 NorA 外排泵的抑制作用。
Microb Pathog. 2019 May;130:242-246. doi: 10.1016/j.micpath.2019.03.012. Epub 2019 Mar 12.
10
Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.金黄色葡萄球菌中存在一种不同于NorA的多药外排转运蛋白的证据。
Antimicrob Agents Chemother. 2000 May;44(5):1404-6. doi: 10.1128/AAC.44.5.1404-1406.2000.

引用本文的文献

1
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3-c][1,2]benzothiazine 5,5-Dioxide Derivatives.诺拉外排泵抑制剂:拓展吡唑并[4,3-c][1,2]苯并噻嗪5,5-二氧化物衍生物的构效关系知识
Arch Pharm (Weinheim). 2025 May;358(5):e70000. doi: 10.1002/ardp.70000.
2
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Strains.喹唑啉和喹啉衍生物作为NorA外排泵抑制剂对抗耐药菌株潜力的体外和体内研究
Antibiotics (Basel). 2025 Mar 26;14(4):339. doi: 10.3390/antibiotics14040339.
3
Screening Privileged Alkyl Guanidinium Motifs under Host-Mimicking Conditions Reveals a Novel Antibiotic with an Unconventional Mode of Action.在模拟宿主条件下筛选特权烷基胍基基序揭示了一种具有非常规作用模式的新型抗生素。
JACS Au. 2024 Jul 16;4(8):3125-3134. doi: 10.1021/jacsau.4c00449. eCollection 2024 Aug 26.
4
Methicillin Resistant : Molecular Mechanisms Underlying Drug Resistance Development and Novel Strategies to Combat.耐甲氧西林:耐药性产生的分子机制及对抗新策略
Infect Drug Resist. 2023 Dec 14;16:7641-7662. doi: 10.2147/IDR.S428103. eCollection 2023.
5
Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.金黄色葡萄球菌中涉及氟喹诺酮类药物耐药发展的基因组改变。
PLoS One. 2023 Jul 26;18(7):e0287973. doi: 10.1371/journal.pone.0287973. eCollection 2023.
6
Fluoroquinolone resistance does not facilitate phage Φ13 integration or excision in .氟喹诺酮耐药性并不促进噬菌体Φ13在……中的整合或切除。
Access Microbiol. 2023 Jun 9;5(6). doi: 10.1099/acmi.0.000583.v4. eCollection 2023.
7
Chemical composition of Kunth essential oil and evaluation of its antimicrobial and modulatory effects on antibiotic resistance, antibiofilm, and cell dimorphism inhibitory activities.昆斯精油的化学成分及其对抗生素耐药性、抗生物膜和细胞二态性抑制活性的抗菌及调节作用评估。
3 Biotech. 2023 Jul;13(7):255. doi: 10.1007/s13205-023-03681-1. Epub 2023 Jun 29.
8
Chalcone Derivatives as Potential Inhibitors of P-Glycoprotein and NorA: An and Study.查尔酮衍生物作为 P-糖蛋白和 NorA 的潜在抑制剂:一项体外和体内研究。
Biomed Res Int. 2022 Mar 26;2022:9982453. doi: 10.1155/2022/9982453. eCollection 2022.
9
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.从喹啉到基于喹唑啉的金黄色葡萄球菌 NorA 外排泵抑制剂:通过偶联聚焦的骨架跳跃方法和药效团搜索。
ChemMedChem. 2021 Oct 6;16(19):3044-3059. doi: 10.1002/cmdc.202100282. Epub 2021 Jun 26.
10
Analysis of Multidrug Resistance in Staphylococcus aureus with a Machine Learning-Generated Antibiogram.基于机器学习的药敏分析对金黄色葡萄球菌的多药耐药性研究。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.02132-20.

本文引用的文献

1
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae.肺炎链球菌中赋予氟喹诺酮耐药性的parE基因突变特征分析。
Antimicrob Agents Chemother. 1997 May;41(5):1166-7. doi: 10.1128/AAC.41.5.1166.
2
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.拓扑异构酶IV中的喹诺酮耐药性突变:与flqA位点的关系以及金黄色葡萄球菌中拓扑异构酶IV是氟喹诺酮类药物的主要靶点而DNA回旋酶是次要靶点的遗传学证据。
Antimicrob Agents Chemother. 1996 Aug;40(8):1881-8. doi: 10.1128/AAC.40.8.1881.
3
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.负责金黄色葡萄球菌喹诺酮耐药性的DNA拓扑异构酶IV grlA基因的改变。
Antimicrob Agents Chemother. 1996 May;40(5):1157-63. doi: 10.1128/AAC.40.5.1157.
4
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.金黄色葡萄球菌中诱导型NorA介导的多重耐药性。
Antimicrob Agents Chemother. 1995 Dec;39(12):2650-5. doi: 10.1128/AAC.39.12.2650.
5
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.金黄色葡萄球菌中由外排介导的氟喹诺酮耐药性。
Antimicrob Agents Chemother. 1993 May;37(5):1086-94. doi: 10.1128/AAC.37.5.1086.
6
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.新型氟喹诺酮类药物CP-99,219对革兰氏阳性菌临床分离株的体外活性
Antimicrob Agents Chemother. 1993 Feb;37(2):366-70. doi: 10.1128/AAC.37.2.366.
7
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.金黄色葡萄球菌的氟喹诺酮抗性蛋白NorA是一种多药外排转运蛋白。
Antimicrob Agents Chemother. 1993 Jan;37(1):128-9. doi: 10.1128/AAC.37.1.128.
8
Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine.枯草芽孢杆菌多药转运蛋白Bmr的突变体,对降压生物碱利血平的敏感性发生改变。
J Biol Chem. 1993 May 25;268(15):11086-9.
9
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.由norA介导的喹诺酮耐药性:生理学特征及其与flqB的关系,flqB是金黄色葡萄球菌染色体上的一个喹诺酮耐药位点。
Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55. doi: 10.1128/AAC.38.6.1345.
10
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.金黄色葡萄球菌DNA拓扑异构酶IV的克隆及一级结构:氟喹诺酮类药物的主要作用靶点
Mol Microbiol. 1994 Aug;13(4):641-53. doi: 10.1111/j.1365-2958.1994.tb00458.x.

金黄色葡萄球菌基因相关菌株中氟喹诺酮耐药机制

Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus.

作者信息

Kaatz G W, Seo S M

机构信息

Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

出版信息

Antimicrob Agents Chemother. 1997 Dec;41(12):2733-7. doi: 10.1128/AAC.41.12.2733.

DOI:10.1128/AAC.41.12.2733
PMID:9420048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC164198/
Abstract

Fluoroquinolone resistance in Staphylococcus aureus results from amino acid substitutions at particular locations in the DNA gyrase A and B subunits as well as in the topoisomerase IV A subunit and from NorA-mediated efflux. More than one resistance mechanism may be present in a single strain. Fluoroquinolone-resistant derivatives of SA-1199, a methicillin-susceptible S. aureus strain, were selected in vivo or in vitro, and their mechanisms of fluoroquinolone resistance were identified. We found that many of the resistance mechanisms described above can develop in derivatives of a single parent strain, either singly or in combination, and can arise in a single step. Variances in MICs for strains with the same apparent resistance mechanisms likely are due to the presence of new or undetected but established means of fluoroquinolone resistance. NorA-mediated resistance can occur in the apparent absence of topoisomerase mutations and in some strains may be the result of a promoter region mutation causing increased expression of norA. However, increased expression of norA can occur independently of this mutation, suggesting that a regulatory locus for this gene exists elsewhere on the chromosome.

摘要

金黄色葡萄球菌对氟喹诺酮类药物的耐药性源于DNA旋转酶A和B亚基以及拓扑异构酶IV A亚基特定位置的氨基酸取代,以及NorA介导的外排作用。单个菌株中可能存在不止一种耐药机制。在体内或体外筛选出了对甲氧西林敏感的金黄色葡萄球菌菌株SA - 1199的氟喹诺酮耐药衍生物,并确定了它们对氟喹诺酮的耐药机制。我们发现,上述许多耐药机制可以在单个亲本菌株的衍生物中单独或联合出现,并且可以在一步中产生。具有相同明显耐药机制的菌株在最低抑菌浓度(MIC)上的差异可能是由于存在新的或未检测到但已确定的氟喹诺酮耐药方式。NorA介导的耐药性可能在明显不存在拓扑异构酶突变的情况下发生,并且在某些菌株中可能是启动子区域突变导致norA表达增加的结果。然而,norA的表达增加可以独立于这种突变发生,这表明该基因的调控位点存在于染色体的其他位置。